Double Positive CD4+CD8+ T Cells: Key Suppressive Role in the Production of Autoantibodies in Systemic Lupus Erythematosus

Overview

Journal Indian J Med Res

Specialty General Medicine

Date 2014 Dec 10

PMID 25488445

Citations 13

Authors

Yongkang Wu

Bei Cai

Weihua Feng

Bin Yang

Zhuochun Huang

Chuan Zuo

Lanlan Wang

Affiliations

Soon will be listed here.

Abstract

Background & Objectives: The presence of CD4+CD8+ (double positive) T cells (DPT) in the target organs of several autoimmune diseases has been reported. The aim of this study was to investigate the pathogenic role of DPT in systemic lupus erythematosus (SLE).

Methods: A total of 175 SLE cases and 125 matched healthy controls were investigated for CD3+, CD4+, CD8+ lymphocytes and DPT by flow cytometry. Serum samples from SLE patients and controls were tested for antinuclear antibody (ANA), anti-double strain deoxyribonucleic acid (anti-dsDNA), anti-U1 ribonucleoprotein (anti-U1 RNP), anti-sjogren syndrome A (anti-SSA), anti-ribosomal P protein (anti-rib-P), anti-Smith (anti-Sm), anti-Sjogren syndrome B (anti-SSB), complement 3 (C3) and complement 4 (C4).

Results: The DPT median and 5-95 per cent range of SLE cases and healthy controls were 0.50 [0.10-2.60] and 0.80 [0.20-2.74] respectively (P<0.001). SLE patients were divided into a ≥1:1000 subgroup and a <1:1000 subgroup according to the ANA titre. The DPT of the former subgroup was significantly lower than that of the latter (P=0.032). The DPT medians of positive subgroups with anti-dsDNA (P<0.001), anti-U1RNP (P=0.018), anti-SSA (P=0.021) or anti-rib-P (P=0.039) were also significantly lower than the negative subgroups. Likewise, DPT was significantly lower in SLE subgroups with low concentration of C3 or C4 than those with high concentration (P<0.006).

Interpretation & Conclusions: Our findings show that the DPT cells may play a key suppressive role in the production of autoantibodies in SLE. Direct evidence that DPT regulates the pathogenesis of SLE needs to be investigated in future work.

Citing Articles

Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE.

Lyu M, Tang X, Raso M, Huang M, Zeng K, Sadeghi T Front Immunol. 2025; 16:1449693.

PMID: 39975551 PMC: 11836023. DOI: 10.3389/fimmu.2025.1449693.

Comparative Analysis of Maternal Colostrum and Colostrum Replacer Effects on Immunity, Growth, and Health of Japanese Black Calves.

Urakawa M, Baakhtari M, Ramah A, Imatake S, Ahmadi P, Deguchi Y Animals (Basel). 2024; 14(2).

PMID: 38275805 PMC: 10812718. DOI: 10.3390/ani14020346.

Allogeneic cord blood regulatory T cells decrease dsDNA antibody and improve albuminuria in systemic lupus erythematosus.

Lyu M, Tang X, Khoury J, Raso M, Huang M, Zeng K Front Immunol. 2023; 14:1217121.

PMID: 37736101 PMC: 10509479. DOI: 10.3389/fimmu.2023.1217121.

Characteristics and clustering analysis of peripheral blood lymphocyte subsets in children with systemic lupus erythematosus complicated with clinical infection.

Deng Y, Ou Y, Mo C, Huang L, Qin X Clin Rheumatol. 2023; 42(12):3299-3309.

PMID: 37537315 DOI: 10.1007/s10067-023-06716-3.

Regulatory effect of Pseudomonas aeruginosa mannose-sensitive hemagglutinin on inflammation and immune function in percutaneous nephrolithotomy patients with upper urinary tract calculi complicated with infection.

Zhao Y, Zhang Y, Liu J Front Immunol. 2023; 14:1181688.

PMID: 37377966 PMC: 10291127. DOI: 10.3389/fimmu.2023.1181688.

References

BLUE M, Daley J, Levine H, Craig K, Schlossman S . Biosynthesis and surface expression of T8 by peripheral blood T4+ cells in vitro. J Immunol. 1986; 137(4):1202-7. View

Das G, Augustine M, Das J, Bottomly K, Ray P, Ray A . An important regulatory role for CD4+CD8 alpha alpha T cells in the intestinal epithelial layer in the prevention of inflammatory bowel disease. Proc Natl Acad Sci U S A. 2003; 100(9):5324-9. PMC: 154344. DOI: 10.1073/pnas.0831037100. View

Nascimbeni M, Pol S, Saunier B . Distinct CD4+ CD8+ double-positive T cells in the blood and liver of patients during chronic hepatitis B and C. PLoS One. 2011; 6(5):e20145. PMC: 3102078. DOI: 10.1371/journal.pone.0020145. View

Desfrancois J, Derre L, Corvaisier M, Le Mevel B, Catros V, Jotereau F . Increased frequency of nonconventional double positive CD4CD8 alphabeta T cells in human breast pleural effusions. Int J Cancer. 2009; 125(2):374-80. DOI: 10.1002/ijc.24366. View

Grondal G, Gunnarsson I, Ronnelid J, Rogberg S, Klareskog L, Lundberg I . Cytokine production, serum levels and disease activity in systemic lupus erythematosus. Clin Exp Rheumatol. 2000; 18(5):565-70. View

Parel Y, Chizzolini C . CD4+ CD8+ double positive (DP) T cells in health and disease. Autoimmun Rev. 2004; 3(3):215-20. DOI: 10.1016/j.autrev.2003.09.001. View

Kyttaris V, Tsokos G . T lymphocytes in systemic lupus erythematosus: an update. Curr Opin Rheumatol. 2004; 16(5):548-52. DOI: 10.1097/01.bor.0000132646.55056.e0. View

Ghosh P, Dwivedi S, Naik S, Agarwal V, Verma A, Aggarwal A . Antinuclear antibodies by indirect immunofluorescence : optimum screening dilution for diagnosis of systemic lupus erythematosus. Indian J Med Res. 2007; 126(1):34-8. View

Desfrancois J, Moreau-Aubry A, Vignard V, Godet Y, Khammari A, Dreno B . Double positive CD4CD8 alphabeta T cells: a new tumor-reactive population in human melanomas. PLoS One. 2010; 5(1):e8437. PMC: 2797605. DOI: 10.1371/journal.pone.0008437. View

10.

Rahemtullah A, Lee Harris N, Dorn M, Preffer F, Hasserjian R . Beyond the lymphocyte predominant cell: CD4+CD8+ T-cells in nodular lymphocyte predominant Hodgkin lymphoma. Leuk Lymphoma. 2008; 49(10):1870-8. DOI: 10.1080/10428190802308728. View

11.

Crispin J, Oukka M, Bayliss G, Cohen R, Van Beek C, Stillman I . Expanded double negative T cells in patients with systemic lupus erythematosus produce IL-17 and infiltrate the kidneys. J Immunol. 2008; 181(12):8761-6. PMC: 2596652. DOI: 10.4049/jimmunol.181.12.8761. View

12.

Brod S, Purvee M, Benjamin D, Hafler D . Frequency analysis of CD4+CD8+ T cells cloned with IL-4. Cell Immunol. 1990; 125(2):426-36. DOI: 10.1016/0008-8749(90)90096-a. View

13.

Jacob N, Stohl W . Autoantibody-dependent and autoantibody-independent roles for B cells in systemic lupus erythematosus: past, present, and future. Autoimmunity. 2009; 43(1):84-97. PMC: 2809122. DOI: 10.3109/08916930903374600. View

14.

Chauhan N, Vajpayee M, Mojumdar K, Singh R, Singh A . Study of CD4+CD8+ double positive T-lymphocyte phenotype and function in Indian patients infected with HIV-1. J Med Virol. 2012; 84(6):845-56. DOI: 10.1002/jmv.23289. View

15.

Laky K, Fleischacker C, Fowlkes B . TCR and Notch signaling in CD4 and CD8 T-cell development. Immunol Rev. 2006; 209:274-83. DOI: 10.1111/j.0105-2896.2006.00358.x. View

16.

Nasiri S, Karimifar M, Bonakdar Z, Salesi M . Correlation of ESR, C3, C4, anti-DNA and lupus activity based on British Isles Lupus Assessment Group Index in patients of rheumatology clinic. Rheumatol Int. 2009; 30(12):1605-9. DOI: 10.1007/s00296-009-1201-3. View

17.

Zuckermann F . Extrathymic CD4/CD8 double positive T cells. Vet Immunol Immunopathol. 1999; 72(1-2):55-66. DOI: 10.1016/s0165-2427(99)00118-x. View

18.

Tackey E, Lipsky P, Illei G . Rationale for interleukin-6 blockade in systemic lupus erythematosus. Lupus. 2004; 13(5):339-43. PMC: 2014821. DOI: 10.1191/0961203304lu1023oa. View

19.

Terabe M, Park J, Berzofsky J . Role of IL-13 in regulation of anti-tumor immunity and tumor growth. Cancer Immunol Immunother. 2003; 53(2):79-85. PMC: 11034335. DOI: 10.1007/s00262-003-0445-0. View

20.

Yu C, Gershwin M, Chang C . Diagnostic criteria for systemic lupus erythematosus: a critical review. J Autoimmun. 2014; 48-49:10-3. DOI: 10.1016/j.jaut.2014.01.004. View